BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 22828739)

  • 21. Early Steroid Withdrawal Protocol With Basiliximab and Rituximab in ABO-Incompatible Kidney Transplant Recipients.
    Tojimbara T; Yashima J; Shirai H; Yamazaki T; Koyama I; Nakajima I
    Transplant Proc; 2020; 52(6):1705-1708. PubMed ID: 32444132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excellent outcomes of ABO-incompatible kidney transplantation: a single-center experience.
    Uchida J; Kuwabara N; Machida Y; Iwai T; Naganuma T; Kumada N; Nakatani T
    Transplant Proc; 2012 Jan; 44(1):204-9. PubMed ID: 22310615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-AB titer changes in patients with ABO incompatibility after living related kidney transplantations: survey of 101 cases to determine whether splenectomies are necessary for successful transplantation.
    Ishida H; Koyama I; Sawada T; Utsumi K; Murakami T; Sannomiya A; Tsuji K; Yoshimura N; Tojimbara T; Nakajima I; Tanabe K; Yamaguchi Y; Fuchinoue S; Takahashi K; Teraoka S; Ito K; Toma H; Agishi T
    Transplantation; 2000 Aug; 70(4):681-5. PubMed ID: 10972229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
    Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
    Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis.
    Sawada T; Fuchinoue S; Teraoka S
    Transplantation; 2002 Nov; 74(9):1207-10. PubMed ID: 12451255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
    Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S
    Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The low dose of rituximab in ABO-incompatible kidney transplantation without a splenectomy: a single-center experience.
    Shirakawa H; Ishida H; Shimizu T; Omoto K; Iida S; Toki D; Tanabe K
    Clin Transplant; 2011; 25(6):878-84. PubMed ID: 21175849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isoagglutinin adsorption in ABO-incompatible transplantation.
    Genberg H; Kumlien G; Wennberg L; Tydén G
    Transfus Apher Sci; 2010 Oct; 43(2):231-5. PubMed ID: 20667787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of rituximab dosage for ABO-incompatible living-donor kidney transplantation.
    Nakao T; Ushigome H; Kawai K; Nakamura T; Harada S; Koshino K; Suzuki T; Ito T; Nobori S; Yoshimura N
    Transplant Proc; 2015 Apr; 47(3):644-8. PubMed ID: 25891703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma exchange conditioning for ABO-incompatible renal transplantation.
    Winters JL; Gloor JM; Pineda AA; Stegall MD; Moore SB
    J Clin Apher; 2004; 19(2):79-85. PubMed ID: 15274200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between response to rituximab and antibody-mediated rejection in ABO-incompatible living kidney transplantation.
    Maenosono R; Unagami K; Kakuta Y; Furusawa M; Okumi M; Azuma H; Ishida H; Tanabe K
    Int J Urol; 2019 Dec; 26(12):1114-1120. PubMed ID: 31522467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of isoagglutinin titer in ABO-incompatible kidney transplantation.
    Won D; Choe W; Kim HJ; Kwon SW; Han DJ; Park SK
    J Clin Apher; 2014 Oct; 29(5):243-50. PubMed ID: 24375675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ABO-incompatible kidney transplantation using both A2 and non-A2 living donors.
    Gloor JM; Lager DJ; Moore SB; Pineda AA; Fidler ME; Larson TS; Grande JP; Schwab TR; Griffin MD; Prieto M; Nyberg SL; Velosa JA; Textor SC; Platt JL; Stegall MD
    Transplantation; 2003 Apr; 75(7):971-7. PubMed ID: 12698082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First two ABO-incompatible living renal transplantations using splenectomy, rituximab, plasmapheresis and IVIG as a preconditioning regimen: a single center experience in the Balkans.
    Ivanovski N; Popov Z; Masin-Spasovska J; Dimcevska AH; Kolevski P
    Xenotransplantation; 2006 Mar; 13(2):123-5. PubMed ID: 16623805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Our first experiences in applying an original method for removal of ABO-isoagglutinins in ABO-incompatible kidney recipients.
    Ignjatović L; Kovacević Z; Jovanović D; Vavić N; Paunić Z; Radojević M; Rabrenović V; Obrencević K; Mijusković M; Draskovic-Pavlović B; Ostojić G; Balint B; Bokonjić D
    Vojnosanit Pregl; 2009 Feb; 66(2):117-22. PubMed ID: 19281122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ABO-incompatible living donor kidney transplantation without post-transplant therapeutic plasma exchange.
    Yabu JM; Fontaine MJ
    J Clin Apher; 2015 Dec; 30(6):340-6. PubMed ID: 25739580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ABO-incompatible renal transplantation at Tokyo Women's Medical University.
    Tanabe K; Tokumoto T; Ishida H; Toma H; Nakajima I; Fuchinoue S; Teraoka S
    Clin Transpl; 2003; ():175-81. PubMed ID: 15387109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of kidney transplantation from ABO-incompatible living donors in a single institution.
    Kenmochi T; Saigo K; Maruyama M; Akutsu N; Iwashita C; Otsuki K; Ito T; Suzuki A; Miyazaki M
    Transplant Proc; 2008 Sep; 40(7):2289-91. PubMed ID: 18790214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ABO-incompatible kidney transplantation: first cases in Turkey.
    Tuncer M; Yücetin L; Tekin S; Demirbas A
    Transplant Proc; 2012; 44(6):1703-5. PubMed ID: 22841248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report.
    Nakamura Y; Hama K; Iwamoto H; Yokoyama T; Kihara Y; Konno O; Jojima Y; Shimazu M
    Transplant Proc; 2012 Mar; 44(2):565-9. PubMed ID: 22410070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.